NCT04968002 2021-07-20Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer: A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant TherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2/3 Unknown40 enrolled